Risk factors for nephrotoxicity associated with conventional amphotericin B therapy.
D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D056487:Chemical and Drug Induced Liver Injury, Chronic / Q000209:etiology* / Q000517:prevention & control; D004334:Drug Administration Schedule; D006801:Humans; D007262:Infusions, Intravenous; D011446:Prospective Studies; D015532:Rehydration Solutions / Q000008:administration & dosage; D012307:Risk Factors; D012964:Sodium / Q000008:administration & dosage
D000935:Antifungal Agents; D015532:Rehydration Solutions; D000666:Amphotericin B; D012964:Sodium